PCM
EXAS

Peregrine Capital Management’s Exact Sciences EXAS Stock Holding History

Peregrine Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-427,748
Closed -$43.4M – 304
2025
Q4 		$43.4M Sell
427,748
-465,241
-52% -$37.4M 1.33% 18
2025
Q3 		$48.9M Buy
892,989
+70,372
+9% +$3.52M 1.47% 14
2025
Q2 		$43.7M Buy
822,617
+117,331
+17% +$5.96M 1.32% 16
2025
Q1 		$30.5M Sell
705,286
-24,454
-3% -$1.24M 1.01% 22
2024
Q4 		$41M Sell
729,740
-34,478
-5% -$2.15M 1.21% 19
2024
Q3 		$52.1M Sell
764,218
-4,422
-0.6% -$250K 1.57% 14
2024
Q2 		$32.5M Buy
768,640
+114,047
+17% +$6.28M 0.95% 22
2024
Q1 		$45.2M Sell
654,593
-4,110
-0.6% -$260K 1.3% 17
2023
Q4 		$48.7M Buy
658,703
+96,778
+17% +$6.34M 1.46% 14
2023
Q3 		$38.3M Sell
561,925
-563
-0.1% -$47.8K 1.14% 17
2023
Q2 		$52.8M Sell
562,488
-6,009
-1% -$469K 1.44% 10
2023
Q1 		$38.5M Sell
568,497
-36,959
-6% -$2.38M 1.11% 14
2022
Q4 		$30M Buy
605,456
+165,439
+38% +$6.76M 0.94% 18
2022
Q3 		$14.3M Sell
440,017
-5,941
-1% -$245K 0.46% 45
2022
Q2 		$17.6M Sell
445,958
-23,058
-5% -$1.23M 0.53% 36
2022
Q1 		$32.8M Sell
469,016
-42,323
-8% -$3.09M 0.78% 24
2021
Q4 		$39.8M Buy
511,339
+132,382
+35% +$11.7M 0.8% 25
2021
Q3 		$36.2M Buy
378,957
+31,501
+9% +$3.33M 0.75% 26
2021
Q2 		$43.2M Buy
347,456
+43,521
+14% +$5.19M 0.77% 26
2021
Q1 		$40.1M Buy
303,935
+21,595
+8% +$2.96M 0.74% 19
2020
Q4 		$37.4M Buy
282,340
+39,371
+16% +$4.76M 0.71% 24
2020
Q3 		$24.8M Buy
+242,969
New +$21M 0.66% 41

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Peregrine Capital Management's EXAS Position: Q1 2026 in Review

Peregrine Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 427,748 shares — an estimated $43.4M sold.

Peregrine Capital Management first reported a position in EXAS in Q3 2020 and held it in 22 quarters. The position peaked at $52.8M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Peregrine Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Peregrine Capital Management sold 427,748 Exact Sciences shares in Q1 2026, an estimated $43.4M.
  • Peregrine Capital Management first reported a position in Exact Sciences in Q3 2020 and held it in 22 quarters.
  • Peregrine Capital Management's Exact Sciences position peaked at $52.8M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Peregrine Capital Management's 13F filing for Q1 2026, filed 23 Apr 2026.